Dietary Supplements Containing Ephedra Alkaloids Recalled

Finemost Corporation, which does business as (dba) Qualiherb, is issuing a nationwide recall of its dietary supplements sold under the brand name Qualiherb, the U.S. Food and Drug Administration (FDA) just announced.

Finemost is located at 13839 Bentley Place, Cerritos, California, 90703.

The following products are involved in the recall

• Shi Shen Tang: Item number 20217, Mfg. No. CP10217, Mahuang and Cimicifuga Combination.
• Ding Chuan Tang: Item number 20802, Mfg. No. 2008-12, Mahuang and Ginkgo Combination.
• Shen Mi Tang: Item number 21022m Mfg. No. CP11022, Mahuang and Magnolia Combination.
• Xu Ming Tang: Item number 22101, Mfg. No. P122101, Mahuang and Ginseng Combination.

Qualiherb was notified by representatives of the FDA that laboratory analysis by the agency of Shi ShenTang, Shen Mi Tang, and Xu Ming Tang samples revealed that the recalled products contain the presence of ephedrine alkaloids.

FDA has concluded that dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events including heart attack, stroke, and death and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use or under ordinary conditions of use if the labeling is silent.

Qualiherb advises any customers in possession of these defective, recalled products with matching lot numbers to return any unused products to the company directly for a full refund. Customers can call Quality Control at 1.800.533.5907, Monday through Friday 8:30 a.m. to 5:00 p.m., Pacific Standard Time (PST), for instructions on the return and refund process.

Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA’s MedWatch Program: Online at www.fda.gov/medwatch/report.htm; by Fax at 1.800.FDA.0178; or by Regular Mail by using postage-paid FDA form 3500 available at www.fda.gov/MedWatch/getforms.htm, which should then be mailed to MedWatch, FDA, 5600 Fishers Lane, Rockville, Maryland, 20852-9787.

This entry was posted in Pharmaceuticals. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.